Annual Revenue
N/A
31 December 2023
Summary:
XTL Biopharmaceuticals annual revenue is not available.XTLB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly revenue is not available.XTLB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
31 March 2024
Summary:
XTL Biopharmaceuticals TTM revenue is not available.XTLB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
XTLB Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
XTL Biopharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | - | -$1.66 M(-450.5%) | $0.00(-100.0%) |
| Sept 2013 | - | $473.00 K(-7.6%) | $1.31 M(+11.0%) |
| June 2013 | - | $512.00 K(-23.9%) | $1.19 M(+76.1%) |
| Mar 2013 | - | $673.00 K(-296.2%) | $673.00 K(>+9900.0%) |
| Dec 2012 | - | -$343.00 K(-200.0%) | $0.00(-100.0%) |
| Sept 2012 | - | $343.00 K(-82.8%) | $343.00 K(-94.2%) |
| Dec 2008 | $5.94 M(+554.9%) | - | - |
| Sept 2008 | - | $2.00 M(+1.5%) | $5.94 M(+42.6%) |
| June 2008 | - | $1.97 M(0.0%) | $4.17 M(+80.3%) |
| Mar 2008 | - | $1.97 M(+771.7%) | $2.31 M(+307.4%) |
| Dec 2007 | $907.00 K | - | - |
| Sept 2007 | - | $226.00 K(+98.2%) | $567.00 K(+24.6%) |
| June 2007 | - | $114.00 K(0.0%) | $455.00 K(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $114.00 K(+0.9%) | $455.00 K(0.0%) |
| Dec 2006 | $454.00 K(-85.8%) | $113.00 K(-0.9%) | $455.00 K(-28.5%) |
| Sept 2006 | - | $114.00 K(0.0%) | $636.00 K(-22.2%) |
| June 2006 | - | $114.00 K(0.0%) | $817.00 K(-59.6%) |
| Mar 2006 | - | $114.00 K(-61.2%) | $2.02 M(-37.1%) |
| Dec 2005 | $3.20 M(-7.4%) | $294.00 K(-0.3%) | $3.21 M(-15.0%) |
| Sept 2005 | - | $295.00 K(-77.6%) | $3.78 M(-13.1%) |
| June 2005 | - | $1.32 M(+1.1%) | $4.35 M(+28.3%) |
| Mar 2005 | - | $1.30 M(+51.3%) | $3.39 M(+14.9%) |
| Dec 2004 | $3.45 M | $862.00 K(-0.2%) | $2.95 M(+41.3%) |
| Sept 2004 | - | $864.00 K(+140.7%) | $2.09 M(+70.6%) |
| June 2004 | - | $359.00 K(-58.4%) | $1.22 M(+41.6%) |
| Mar 2004 | - | $864.00 K | $864.00 K |
FAQ
- What is the all time high annual revenue for XTL Biopharmaceuticals?
- What is the all time high quarterly revenue for XTL Biopharmaceuticals?
- What is the all time high TTM revenue for XTL Biopharmaceuticals?
What is the all time high annual revenue for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual revenue is $5.94 M
What is the all time high quarterly revenue for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly revenue is $2.00 M
What is the all time high TTM revenue for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high TTM revenue is $5.94 M